Investigation of POsaconazole Prophylaxis in Children With Chronic Granulomatous Disease (CGD): Pharmacokinetics and Tolerability (iPOD)

NCT00799071 Phase 2 COMPLETED

The purpose of this study is to find a dose for a twice daily regimen for posaconazole (PSZ) as prophylactic treatment in children with CGD, based on the PSZ trough level.

Details

Lead sponsor	Radboud University Medical Center
Phase	Phase 2
Status	COMPLETED
Enrolment	12
Start date	2009-02
Completion	2010-08

Conditions

• Chronic Granulomatous Disease

Interventions

• posaconazole (PSZ)

Primary outcomes

• Posaconazole trough levels — Day 10; 20; 30

Countries

Netherlands